3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Myelodysplastic Syndromes
9
Leukemia, Myeloid, Acute
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Leukemia
4
Multiple Myeloma
3
Lymphoma
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Hematologic Neoplasms
3
Primary Myelofibrosis
2
Lymphoma, Non-Hodgkin
2
Leukemia, Myelomonocytic, Juvenile
2
Hodgkin Disease
2
Waldenstrom Macroglobulinemia
1
Sarcoma, Ewing
1
Rhabdoid Tumor
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Philadelphia Chromosome
1
Pathologic Complete Response
1
Neuroectodermal Tumors, Primitive
1
Neuroblastoma
1
Myeloid Diseases
1
Myasthenia Gravis
1
Medulloblastoma
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, T-Cell
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Interventions
Cyclophosphamide
9
Topotecan
5
Temozolomide
5
Melphalan
5
Irinotecan
5
Busulfan
5
fludarabine
4
Granulocyte Colony-Stimulating Factor
4
Filgrastim
4
liposomal doxorubicin
3
fludarabine phosphate
3
cabozantinib
3
Vincristine
3
regorafenib
2
pegfilgrastim
2
Sirolimus
2
Doxorubicin
2
Bone Marrow Transplantation
2
trioctyl phosphine oxide
1
trifluridine tipiracil drug combination
1
thymoglobulin
1
talazoparib
1
selinexor
1
seclidemstat
1
racotumomab
1
poly ICLC
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
olaparib
1
niraparib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Sarcoma, Ewing
×
thymoglobulin
×
Clear all
NCT02472392
2017-05-09
Ewing/Allo
University of Louisville
Phase 1
Completed
10 enrolled